Showing results 7 to 26 of 41
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 2021 | Colorectal carcinoma: Evaluation of systemic values of interleukin-1 and interleukin-33 in patients with and without thrombocytosis | Jocic M.; Gajovic N.; Jurisevic M.; Jovanovic M.; Zdravković N.; Arsenijevic, Nebojsa; Dejanović V.; Maric V.; Milev B.; Jovanovic M. |
| 2018 | Diverse expression of IL-32 in diffuse and intestinal types of gastric cancer | Pavlovic, Mladen; Gajovic N.; Jurisevic M.; Mitrovic M.; Radosavljevic, Gordana; Pantic, Jelena; Arsenijevic, Nebojsa; Jovanovic I. |
| 2018 | DNA binding and antitumor activities of platinum(IV) and zinc(II) complexes with some S-alkyl derivatives of thiosalicylic acid | Besser Silconi Z.; Benazic S.; Milovanovic, Jelena; Jurisevic M.; Djordjevic, Dragana; Nikolic, Milos; Mijajlovic M.; Ratković, Zoran; Radic G.; Radisavljević, Snežana; Petrović, Biljana; Radosavljevic, Gordana; Milovanovic, Marija; Arsenijevic, Nebojsa |
| 2022 | Dual blockage of PD-L/PD-1 and IL33/ST2 axes slows tumor growth and improves antitumor immunity by boosting NK cells | Jovanovic, Marina; Geller D.; Gajovic, Nevena; Jurisevic, Milena; Arsenijevic, Nebojsa; Jovanovic, Milan; Supic, Gordana; Vojvodic, Danilo; Jovanovic, Ivan |
| 2015 | Early cytokine profile changes in interstitial and necrotic forms of acute pancreatitis | Kostic I.; Spasic M.; Stojanovic B.; Jurisevic M.; Radovanovic D.; Canovic D.; Stefanovic, Srdjan; Jankovic, Slobodan |
| 2015 | End-of-life costs of medical care for advanced stage cancer patients | Kovacevic, Aleksandra; Dragojević Simić, Viktorija; Rancic, Nemanja; Jurisevic, Milena; Gutzwiller, Florian S.; Matter-Walstra K.; Jakovljevic, Mihajlo |
| 2015 | Evolution of the Serbian pharmaceutical market alongside socioeconomic transition | Jakovljevic, Mihajlo; Djordjevic, Natasa; Jurisevic M.; Jankovic, Slobodan |
| 2019 | Fecal galectin-1 as a potential marker for colorectal cancer and disease severity | Jovanovic M.; Gajovic N.; Zdravković N.; Jovanovic M.; Jurisevic M.; Vojvodic, Danilo; Mirkovic D.; Milev B.; Maric V.; Arsenijevic, Nebojsa |
| 2018 | Fecal galectin-3: a new promising biomarker for severity and progression of colorectal carcinoma | Jovanovic M.; Gajovic, Nevena; Zdravkovic, Natasa; Jovanovic, Marina; Jurisevic, Milena; Vojvodic, Danilo; Maric V.; Arsenijević, Aleksandar; Jovanovic, Ivan |
| 2019 | Fecal sST2 correlates with the disease severity of ulcerative colitis | Jovanovic M.; Gajovic N.; Jurisevic M.; Markovic B.; Maric V.; Jovanovic M.; Arsenijevic, Nebojsa; Zdravković N. |
| 2022 | Galectin-1 as the new player in staging and prognosis of COVID-19 | Sekulic Markovic, Sofija; Gajovic, Nevena; Jurisevic, Milena; Jovanovic, Marina; Popovska Jovicic, Biljana; Arsenijevic, Nebojsa; Mijailovic, Zeljko; Jovanovic, Marina; Dolicanin, Zana; Jovanovic, Ivan |
| 2023 | Galectin-3 as an important prognostic marker for COVID-19 severity | Gajovic, Nevena; Marković, Jordan; Jurisevic, Milena; Jovanovic M.; Arsenijevic, Nebojsa; Mijailovic, Zeljko; Jovanovic M.; Jovanovic I. |
| 2021 | IL 33 Correlates With COVID-19 Severity, Radiographic and Clinical Finding | Sekulic Markovic, Sofija; Jovanovic, Marina; Gajovic, Nevena; Jurisevic, Milena; Arsenijevic, Nebojsa; Jovanovic, Marina; Jovanovic, Milan; Mijailovic, Zeljko; Lukic, Snezana; Zornic, Nenad; Vukicevic, Vladimir; Stojanovic, Jasmina; Maric, Veljko; Jocic, Miodrag; Jovanovic, Ivan |
| 2020 | IL-32 expression associated with lymph vessel invasion in intestinal type of gastric cancer | Pavlovic, Mladen; Jurisevic M.; Gajovic N.; Mitrović P.; Jovanovic M.; Radosavljevic, Gordana; Pantic, Jelena; Radovanovic D.; Arsenijevic, Nebojsa; Jovanovic I. |
| 2020 | Increased il-33 and il-17 in colorectal carcinoma patients with severe disease | Maric, Veljko; Jovanovic, Milan; Zdravkovic, Natasa; Jovanovic, Marina; Gajovic, Nevena; Jurisevic, Milena; Jovanovic, Marina; Jovanovic, Ivan |
| 2021 | Increased severity of ulcerative colitis in the terminal phase of the metabolic syndrome | Jovanovic M.; Jurisevic M.; Gajovic N.; Arsenijevic, Nebojsa; Jocic M.; Jovanovic I.; Zdravković N.; djukic, aleksandar; Maric V.; Jovanovic M. |
| 2020 | Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection | Lukic R.; Čupić, Milan; Gajovic N.; Jurisevic M.; Mijailovic Z.; Davidovic B.; Kujundžic B.; Joksimović B.; Arsenijevic, Nebojsa; Jovanovic I. |
| 2019 | Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression | Jovanovic M.; Simovic Markovic, Bojana; Gajovic N.; Jurisevic M.; djukic, aleksandar; Jovanovic I.; Arsenijevic, Nebojsa; Lukic, Aleksandra; Zdravković N. |
| 2022 | MMP-9/BDNF ratio predicts more severe COVID-19 outcomes | Savic, Gordana; Stevanovic I.; Mihajlovic D.; Jurisevic, Milena; Gajovic, Nevena; Jovanovic, Ivan; Ninkovic M. |
| 2020 | O,O'-diethyl-(S,S)-ethylenediamine-N,N'-di-2-(3-cyclohexyl) propanoate dihydrochloride enhances influx of effective NK and NKT cells in murine breast cancer | Jurisevic M.; Jagić N.; Gajovic N.; Arsenijevic A.; Jovanovic M.; Milovanovic, Marija; Pantic, Jelena; Jovanovic I.; Sabo, Tibor; Radosavljevic, Gordana; Arsenijevic, Nebojsa |